Leadership
Sejin Jang. CEO
- M.D. in School of Medicine, Hanyang University
- Ph.D. in Graduate school of Medicine, Hanyang University
- Head Professor, Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine (Present)
- Chairman of the board, The Korean Society of Pathologist
- Consultant, Health Insurance Dispute Mediation Committee
- Chairman of the board, Korea Institute of Genetic Testing and Evaluation
- Center director, Asan-Danafaber Cancer Genome Research Center
- Visiting Professor, MD Anderson
- Assistant Professor, School of Medicine, Hanyang University
Gunsik Cho. CEO
- Johns Hopkins school of medicine Postdoc fellow
- M.S./Ph.D. POSTECH
- B.S., Life Science, Hanyang University
- CSRO and Chief of Research Center, NEXEL Co., Ltd.
- Commercialization of human induced pluripotent stem cell-derived cells for the first time in Korea
- Development of protein drugs and Engineered cell-based therapeutics
- Participation in HESI Cardiac Safety technical Committee member for the first time in Korea
- The revision of the ICH guideline and an international cardiotoxicity evaluation regulation that is essential for new drug development
